TipRanks
Go Ultimate55% OFF

New China Life Insurance Co., Ltd. Class H (NCL) AI Stock Analysis

1 Followers
DE:NCL

New China Life Insurance Co., Ltd. Class H

(Frankfurt:NCL)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Strong Cash ConversionFree cash flow closely tracking net income indicates that reported profitability is translating into cash rather than relying mainly on accounting accruals. This supports policyholder obligations, capital flexibility, and the company’s ability to sustain operations and investment over the coming quarters.
Negative Factors
Revenue Decline and VolatilityA declining and uneven revenue trajectory makes future earnings less predictable and suggests that recent profitability may not be supported by consistently expanding business volume. Continued volatility could constrain planning, weaken operating leverage, and increase sensitivity to changes in insurance demand.

New China Life Insurance Co., Ltd. Class H (NCL) vs. iShares MSCI Germany ETF (EWG)

-30%-20%-10%0%10%20%30%DE:NCL-13.08%EWG+7.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
EUR 159.09B
Dividend Yield
8.02%
Average Volume (3M)
487
Price to Earnings (P/E)
6.4
Beta (1Y)
0.60
Revenue Growth
34.19%
EPS Growth
42.34%
Country
Germany
Employees
27,726
Sector
Financial
Sector Strength
68
Industry
Insurance - Life

New China Life Insurance Co., Ltd. Class H Business Overview & Revenue Model

Company Description

Headquartered in Beijing, China, New China Life Insurance Company Ltd. was established in 1996 to offer life insurance products and services to individuals and institutions throughout the People's Republic of China. Its operations are structured acro...

New China Life Insurance Co., Ltd. Class H Earnings Call Summary

Earnings Call Date:Mar 26, 2026(Q4-2025)|% Change Since:-5.06%|Next Earnings Date:Mar 31, 2027
Earnings Call SentimentPositive

The call conveyed a largely positive picture: the company reported record highs across assets, premiums, profit, EV and NBV with strong investment returns, marked improvement in persistency and a successful push into participating products and bancassurance. Management acknowledged challenges—solvency pressure from low long-term yields, potential margin effects from the shift to participating business, market/interest-rate uncertainty, and tighter regulatory requirements—but also described concrete mitigation steps (asset-liability matching, diversified investments, capital measures, technology and service investments). Given the scale and materiality of the reported achievements and clear management plans to address risks, the overall tone is constructive and growth-oriented.

Positive Updates

Record Asset and Market Value Growth
Total assets reached close to RMB 1.9 trillion, up 12.2% year-on-year; total market value surpassed RMB 200 billion; share price delivered strong gains (management cited double-digit increases) reflecting improved investor confidence.

Negative Updates

Solvency Pressure from Low-Rate Environment
Although comprehensive solvency margin ratio remained above 200%, management highlighted periodic pressure from sustained downward shifts in long-dated government bond yields (750-day moving average), requiring active capital measures (internal generation, external replenishment, asset allocation optimization).

Company Guidance

Management guidance for 2026 stresses steady, high‑quality growth that balances value and volume by doubling down on a customer‑centered strategy, accelerating the shift to participating whole‑life, annuity and health products, and pushing channel transformation across individual, bancassurance and Internet channels; key 2025 baselines they plan to build on include total assets ≈RMB1.9tn (+12.2%), GWP RMB195.9bn (+14.9%), EV RMB287.8bn (+11.4%), net profit RMB36.3bn (+38.3%), NBV RMB9.8bn (+57.4%) with NBV margin 16.2%, total investment income RMB104.3bn (6.6% yield), and comprehensive solvency margin >200%. Specific operational priorities are to grow participating sales (par FYP RMB11.9bn in 2025; Q4 par mix 77%), expand bancassurance (2025 bank FYP RMB72.1bn, long‑term FYP RMB37.9bn +52%, NBV RMB5.27bn +111%), sustain persistency (13‑month 97.1%, 25‑month 93.3%) and low surrenders (1.5%), optimize asset‑liability matching (including three pilot funds totalling RMB46.25bn and greater allocation to long‑term equity/PE/OCI), maintain capital adequacy via internal and external measures, and scale tech/AI (11 large models and digital ambassadors, target digital productivity ≈3,000 FTE via seven virtual employee roles) while preserving strong service metrics (one‑minute policy service 96%, paid >RMB42bn in maturities/annuities and RMB14.7bn in claims).

New China Life Insurance Co., Ltd. Class H Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

DE:NCL against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
HK:0966HK:096679OutperformHKD 65.09B2.0433.37%6.75%18.51%293.61%
HK:1299HK:129970OutperformHKD 796.17B14.1619.05%2.51%13.31%36.76%
HK:2628HK:262869NeutralHKD 1.07T13.3812.07%4.40%38.17%134.02%
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
HK:2318HK:231866NeutralHKD 1.06T9.999.64%5.88%-7.57%-25.97%
HK:2601HK:260166NeutralHKD 331.66B6.9313.91%6.41%9.37%-11.20%

* Financial Sector Average

Performance Comparison

0%20%40%DE:NCLHK:2318HK:1299HK:2601HK:2628HK:0966Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
DE:NCL and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
DE:NCLNew China Life Insurance Co., Ltd. Class H4.50-0.49-9.87%
HK:2318Ping An Insurance53.45-1.43-2.61%
HK:1299AIA Group 78.85-0.70-0.88%
HK:2601China Pacific Insurance (Group) Co Class H28.20-2.18-7.17%
HK:2628China Life Insurance Co Class H25.620.983.99%
HK:0966China Taiping Insurance Holdings Co 18.221.126.54%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.